The 2010 Investment U Conference is underway! And even if you couldn't make it, now you can "bring home" more than 30 breakthrough presentations from the conference... Order the Deluxe MP3/Video Library for $99 to listen and view on your computer, or the Premier CD plus MP3/Video Library for $149 to listen to and view anywhere.
Risk Returns – And So Does Fear
by The Investment U Research Team
We’re starting to see another emotion climb back into the market mentality in the past couple of days: Fear. After 30 days of positive movement in the S&P 500 (.INX) we’re starting to hear more trepidation and concern that this surge has gotten ahead of itself.
The VIX has been giving signals that September may turn ugly, and European markets stumbled at the prospects that the U.S. economy hasn’t entirely restarted.
After all, we’re already talking about a Goldman Sachs’ (NYSE: GS) Bubble
Early reports that futures and European stocks are moving down today may be overdone though. While the markets may be due for a pullback on fundamentals, this markets is still stretching a little based off market optimism.
We’re not going to see massive drops in the markets as we have in the past year. Quite simply, it’s because there are too many people still sitting on the sidelines. They will use these dips to move back into the markets, and blunt any large downward movements.
After missing the past 30% rise in the indices, they won’t want to miss out, and they will provide a cushion that we haven’t seen for a while as risk has returned.
Symbols mentioned in this article: .INX and GS.
- Look out Below and Overseas
- The CBOE Volatility Index (VIX): Using The Fear/Greed Index to Pinpoint Your Best Time to Profit
- VIX Volatility is Back: Here’s How to Profit from a Complacent Market
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed